But it A new type of drug called dimethyl fumarate was recently approved in Europe as a basic treatment for multiple sclerosis. Various clinical studies have shown that it is effective in treating the symptoms of the said disease. But the underlying mode of action is not entirely known. But now, scientists from Bad Nauheim’s Max Planck
Posted in Multiple Sclerosis 
Tags: basic treatment for ms, central nervous system, immune system, ms drug, ms treatment 
Comments Off on Researchers Discover How New MS Drug Works
Researchers at The Scripps Research Institute (TSRI) have discovered a new treatment strategy that is showing promise so far in mice models of the disease. Unlike current MS treatments, which try to suppress the immune system, the new treatment uses compounds to boost production of progenitor cells that can repair the nerve fibers damaged by
Posted in Multiple Sclerosis Tags: ms drug, ms research, ms treatment, treatment strategy Comments Off on New Treatment Strategies For MS Shows Promise In Mice Model
A new study suggests that a drug known to treat multiple sclerosis may also be effective in preventing one of the leading causes of heart attacks. Researchers from the University of Manchester and the University if Illinois in Chicago have discovered that the drug known as Gilenya, a drug recently approved in the US for
Posted in Multiple Sclerosis Tags: heart attack, heart condition, ms drug, ms drug study, ms treatment Comments Off on Study Suggests MS Drug Also Effective In Preventing Heart Condition
A new multiple sclerosis drug has been showing quite a promise in reducing relapse rates in people who suffer from the said disease. The experimental MS drug called alemtuzumab (Lemtrada) from Genzyme has been showing that it can reduce relapse rates of MS by as much as 50 percent. It is also seen to be
Posted in Multiple Sclerosis Tags: ms drug, ms relapse rate, ms treatment, multiple sclerosis treatment, new ms drug, relapsing remitting ms Comments Off on MS Drug Reduces Relapse Rate By Half In Late Stage Trial
There is some good news for a great number of MS sufferers. A large international clinical trial has provided some good results on an oral drug that was developed to treat people with multiple sclerosis. The results are showing that the said oral drug seems to significantly reduce the relapse rate of the said disease
Posted in Multiple Sclerosis Tags: ms clinical trial, ms drug, ms oral drug, ms treatment, new oral drug, new oral ms drug, oral multiple sclerosis drug Comments Off on New Oral Drug Found to Reduce Relapses in Multiple Sclerosis Patients
Researchers from The Scripps Research Institute in Florida have developed a new class of compounds that have shown to effectively halt the progression of MS in animal models. This new class of highly selective compounds may just lead the way for the researchers to find other more effective therapeutic routes for multiple sclerosis in humans.
Posted in Multiple Sclerosis Tags: immune system, ms drug, ms progression, ms research, ms treatment, new ms drug Comments Off on Compound Stops MS Progression In Animal Model
A new study shows that using a combination of a steroid drug with a multiple sclerosis drug can provide better relief from MS symptoms than using just an MS drug alone. A combination of using the steroid methylprednisolone along with the regular MS treatment drug interferon beta-1a seem to provide better results in terms of
Posted in Multiple Sclerosis Tags: drug combo, ms drug, ms study, ms symptoms, ms treatment, multiple sclerosis drug, steriod drug Comments Off on Drug Combination Relieves MS Symptoms Better
A new drug undergoing a two year phase III TEMSO trial show very good results in the treatment of relapsing multiple Sclerosis. The said drug, called teriflunomide, has significantly reduced the yearly relapse rate by 31 percent as compared to a placebo. The results of the trial also showed a significant reduction on the risk
Posted in Multiple Sclerosis Tags: ms drug, ms drug trial, ms relapses, ms treatment, relapsing ms Comments Off on New Drug Reduces MS Relapses In Patients
